ABOS Stock Analysis: Buy, Sell, or Hold?
ABOS - Acumen Pharmaceuticals, Inc. Common Stock
$2.64
0.01 (0.38%)
▲
5d:
-1.12%
30d:
+17.86%
90d:
+6.88%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
27d
Get Alerted When ABOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ABOS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ABOS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ABOS is currently trading at $2.64, which is considered slightly high relative to its 30-day fair value range of $2.24 to $2.64.
Technical Outlook: Technically, ABOS is in a downtrend. Immediate support is located at $2.38, while resistance sits at $2.83.
Market Sentiment: ABOS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (86th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $7.40 (+180.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABOS is in a downtrend. Immediate support is located at $2.38, while resistance sits at $2.83.
Market Sentiment: ABOS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (86th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $7.40 (+180.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.24 -
$2.64
Company Quality Score
60/100
(HOLD)
Options IV Signal
86th percentile
(EVENT RISK)
Volume Confirmation
HIGH
Confidence Score
62.5%
All Signals
- BEARISH: Options expensive (IV 86th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 180.3% below Wall St target ($7.40)
Trading Range Analysis
30-Day Trading Range
$2.24 -
$2.64
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$0.74
(27.9%)
Support & Resistance Levels
Support Level
$2.38
Resistance Level
$2.83
Current Trend
Downtrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.75
Wall Street Target
$7.40
(+180.3%)
Share & Embed Analysis
Last updated: July 14, 2026 3:06 AM ET
Data refreshes hourly during market hours. Next update: 4:06 AM
Data refreshes hourly during market hours. Next update: 4:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Siemers
SELL
895 shares
2026-01-22
Matt Zuga
SELL
1687 shares
2026-01-22
Russell Barton
SELL
462 shares
2026-01-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 62 BUY |
